SCHEDULE: FMR LLC Discloses 6% Stake in TD SYNNEX Corp

Sentiment:

Beneficial Ownership Report 5 February 2026 1:40 PM

FMR LLC and Abigail P. Johnson have reported a 6.0% beneficial ownership stake in TD SYNNEX Corp's common stock as of December 31, 2025.

Summary

FMR LLC and Abigail P. Johnson, through various affiliated entities, beneficially own 4,909,593.24 shares of TD SYNNEX Corp's common stock.
This represents 6.0% of the total outstanding common stock of TD SYNNEX Corp.
FMR LLC holds sole voting power over 4,879,777.98 shares and sole dispositive power over 4,909,593.24 shares.
Abigail P. Johnson holds sole dispositive power over 4,909,593.24 shares.
The filing is an Amendment No. 26 to a Schedule 13G, indicating an update to a previously reported beneficial ownership.
The securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of TD SYNNEX Corp.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive signal, as a significant 6.0% stake by a major institutional investor like FMR LLC indicates continued confidence in TD SYNNEX Corp, even if it's an amendment to an existing position.

Positives

Negatives

Risks

Future Outlook

Industry Context

StockSavvy.ai notes that institutional ownership disclosures like this Schedule 13G provide transparency into significant holdings by major investment firms, which can influence market perception of the issuer. This filing specifically highlights FMR LLC's continued substantial stake in TD SYNNEX Corp, a key player in technology distribution.

Stakeholder Impact

Shareholders: The disclosure of a significant institutional stake by FMR LLC may be viewed positively by other shareholders, signaling institutional confidence in TD SYNNEX Corp.
Management: The continued substantial ownership by a major institutional investor could imply a level of oversight and engagement, potentially influencing management decisions.

Next Steps

FMR LLC and Abigail P. Johnson will be required to file further amendments to this Schedule 13G if their beneficial ownership of TD SYNNEX Corp's common stock changes significantly (e.g., exceeding 10% or decreasing below 5%, or if there's a material change in the facts previously reported).

Key Dates

Date	Description
2023-01-03	Effective date of Power of Attorney for FMR LLC.
2023-01-10	Date of Schedule 13G filing by FMR LLC (accession number -23-000003) where FMR LLC's Power of Attorney is incorporated by reference.
2023-01-26	Effective date of Power of Attorney for Abigail P. Johnson.
2023-01-31	Date of Schedule 13G filing by FMR LLC (accession number -23-000038) where Abigail P. Johnson's Power of Attorney is incorporated by reference.
2025-12-31	Date of event which requires filing of this statement (reporting period end date).
2026-02-04	Date of filing/signature for this Schedule 13G Amendment No. 26.

Recommendation

hold

This filing is a routine disclosure of beneficial ownership by a major institutional investor, FMR LLC, in TD SYNNEX Corp. While a 6.0% stake is significant and indicates continued institutional confidence, the filing itself does not provide new financial performance data or strategic updates that would warrant a change in investment recommendation. It primarily confirms an existing, albeit updated, ownership position. Therefore, a "hold" recommendation is appropriate as the filing does not present new information to alter an investor's fundamental view of the company.

Keywords

TD SYNNEX CORP, FMR LLC, Abigail P. Johnson, Beneficial Ownership, Schedule 13G, Common Stock, Institutional Ownership, Investment Management, Technology Distribution

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.